Sight Sciences insider plans sale of 1,785 shares
Sight Sciences insider Jeremy Hayden has filed a notice of proposed stock sales under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sight Sciences insider Jeremy Hayden has filed a notice of proposed stock sales under Rule 144. The filing states an intention to sell 1,785 shares of Sight Sciences common stock through Fidelity Brokerage Services on the NASDAQ, with an approximate sale date of January 6, 2026 and an aggregate market value of $13,354.66. These shares were acquired on January 2, 2026 via restricted stock vesting from the issuer as compensation.
The notice also lists recent sales over the prior three months by the same seller, including 3,150 shares sold on November 12, 2025 for gross proceeds of $25,227.78, 44,850 shares sold on November 25, 2025 for $362,596.77, and 9,385 shares sold on January 5, 2026 for $73,418.85. The Rule 144 representation confirms the seller states they are not aware of undisclosed material adverse information about the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.